<unk>  is a hepatitis C virus (HCV) NS5A inhibitor that is FDA approved for the treatment of patients with chronic HCV genotype 1 or 3 infection with sofosbuvir and with or without ribavirin.   Common adverse reactions include headache, anemia, nausea, and fatigue (≥10%).
Daclatasvir
Fomivirsen
Adefovir
Telaprevir
Remdesivir
Entecavir
Tenofovir
Saquinavir